Traditional Chinese Medicine Company Soars Following Experts' Claim That Drug Potentially Inhibits COVID-19
Oct 17, 2020 AM EDT
Guangzhou Baiyunshan Pharmaceutical Holdings shares reportedly jumped "13 percent in Hong Kong, and 10 percent in Shanghai" after the public face of China's fight against the pandemic, Zhong Nanshan, said one of its drugs could possibly stop COVID-19